Radiofrequency ablation of renal allograft cancer: Case report

Saitkarim Abdugafarov 1, Melss Assykbayev 1, Abylaikhan Sharmenov 1, Aygerim Kalzhan 2, Jamilya Saparbay 1 *
More Detail
1 Department of Oncohepatology, Gastroenterology and Organ Transplantation, National
2 Medical School, Medical University Astana, Nur-Sultan city, Republic of Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 18, Issue 3, pp. 62-64. https://doi.org/10.23950/jcmk/10927
OPEN ACCESS 1164 Views 793 Downloads
Download Full Text (PDF)

ABSTRACT

Abstract
Renal cell carcinoma (RCC) of an allograft kidney is an extremely rare type of neoplasm and accounts for about 0.22-0.5% of all kidney recipients. Kidney recipients undergo routine check-up, including ultrasound examination of the graft. RCC is often asymptomatic and can be an incidental finding on routine examination. In this case study, we describe a patient who developed clear cell carcinoma 9 months after the kidney transplantation from a living related donor. Radiofrequency ablation was chosen as the treatment option, considering small size solitary lesion in renal allograft. Complete ablative response was achieved after one treatment. In 4-year follow up period patient did not show any new or recurrent tumor. Radiofrequency ablation is a good therapeutic option for kidney allograft carcinoma.
Keywords: Kidney transplantation, Kidney ablation, Immunosuppression, Kidney transplant cancer.

CITATION

Abdugafarov S, Assykbayev M, Sharmenov A, Kalzhan A, Saparbay J. Radiofrequency ablation of renal allograft cancer: Case report. J CLIN MED KAZ. 2021;18(3):62-4. https://doi.org/10.23950/jcmk/10927

REFERENCES

  • Penn I. Cancer in transplant recipients. Adv Ren Replace Ther 2000; 7(2):147-56.PMID:10782732
  • A.C.W. Chapman Jr and G. Wong, Cancer in the transplant recipient, Cold Spring Harb Perspect Med, vol. 3, no. 7, Article ID a015677, Jul 2013.
  • Favi E., Raison N., Ambrogi F., Delbue S. et al. Systematic review of ablative therapy for treatment of renal allograft neoplasms. World J Clin Cases 2019 September 6; 7(17): 2487-2504 doi: 10.12998/wjcc.v.ii7.2487
  • Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Caddedu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma : comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012 ; 61 :1156-1161[PMID : 22257424 doi : 10.1016/j.eurro.2012.01.001]
  • Thompson RH, Atwell T, Schmitt G, Lohse CM, Kurup AN, Weisbrod A. et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-259 [PMID 25108580 doi: 10.1016/j.euroro.2014.07.2011]
  • Campbell S, Uzzo RG, Allaf ME, Bass EB, Caddedu JA, et al. Renal Mass and Localized Renal Cancer. AUA Guideline. J Urol 2017;198:520-529 [PMID: 28479239 doi: 10.1016/j.juro.2017.04.100
  • Vial T., Descotes J., Immunosuppressive drugs and cancer Toxicology. 2003 Apr 1; 185(3): 229-40. doi: 10.1016/s0300-483x (02)00612-1.
  • Martin P. Gallagher, Patrick J. Kelly, Meg Jardine, Vlado Perkovic, Alan Cass, Jonathan C. Craig, Josette Eris, Angela C. Webster. Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation J Am Soc Nephrol. 2010 May; 21(5): 852–858. doi: 10.1681/ASN.2009101043
  • Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R. Survival on dialysis post-kidney transplant failure: results from the Scientific registry of Transplant Recipients. Am J Kidney Dis 2007; 49: 294-300 [PMID: 17261432 doi:10.1053/j.ajkd.2006.11.022
  • Chambade D, Meria P, Tariel E, Verine J, De Kerviler E, Peraldi MN, Glotz D, Desgrandchamps F, Mogniat-Artus P. Nephron-sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. J Urol 2008;180:2106-2109 [PMID:18804233 doi: 10.1016/j.juro.2008.07.055
  • Lowrance WT, Yee DS, Savage C, Cronin AM, Obrien MF, Donate SM,Vickers A, Russo P Complications after Radical and Partial Nephrectomy as a Function of Age J Urol. 2010 May: 183(5): 1725-1730 doi: 10.1016/j.juro.2009.12.101
  • Barama A, St-Louis G, Nicolet V,Hadjeres R, Daloze P Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 2005;5:3015-3018 [PMID: 16303018 doi: 10.1111/j.1600-6143.2005.01099.x]
  • Gervais D, McGovern FJ, Arellano RS, McDougl WS, Mueller PR Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, Results, and Role in patient management over a 6-year period and ablation of 100 tumors AJR Am J Roentgenol. 2005 Jul; 185(1):64-71. doi: 10.2214/ajr.185.1.01850064